APA (7th ed.) Citation

S, L., AD, S., AE, M., JT, W., & CN, K. (2026). Cost-Effectiveness of ApoB, Non-HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy. JAMA, 335(17), 1507. https://doi.org/10.1001/jama.2026.2986

Chicago Style (17th ed.) Citation

S, Luebbe, Sniderman AD, Moran AE, Wilkins JT, and Kohli-Lynch CN. "Cost-Effectiveness of ApoB, Non-HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy." JAMA 335, no. 17 (2026): 1507. https://doi.org/10.1001/jama.2026.2986.

MLA (9th ed.) Citation

S, Luebbe, et al. "Cost-Effectiveness of ApoB, Non-HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy." JAMA, vol. 335, no. 17, 2026, p. 1507, https://doi.org/10.1001/jama.2026.2986.